RUI; Eugene Yuanjin
Patent Applications and Registrations
Patent applications and USPTO patent grants for RUI; Eugene Yuanjin.The latest application filed is for "modulators of sting (stimulator of interferon genes)".
- RUI; Eugene Yuanjin - San Diego CA
| Patent | Date |
|---|---|
| Modulators of STING (Stimulator of Interferon Genes) App 20220306641 - GAJIWALA; Ketan Satish ; et al. | 2022-09-29 |
| CDK2/4/6 inhibitors Grant 11,396,512 - Behenna , et al. July 26, 2 | 2022-07-26 |
| Anti-proliferative agents for treating PAH Grant 11,203,594 - Bhattacharya , et al. December 21, 2 | 2021-12-21 |
| Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20210230196 - Wythes; Martin James ; et al. | 2021-07-29 |
| Cyclopentane-based modulators of STING (stimulator of interferon genes) Grant 10,968,242 - Wythes , et al. April 6, 2 | 2021-04-06 |
| Modulators of STING (Stimulator of Interferon Genes) App 20210087180 - PATMAN; Ryan ; et al. | 2021-03-25 |
| CDK2/4/6 Inhibitors App 20200392142 - Behenna; Douglas Carl ; et al. | 2020-12-17 |
| Anti-proliferative Agents For Treating Pah App 20200331909 - Bhattacharya; Samit Kumar ; et al. | 2020-10-22 |
| CDK2/4/6 inhibitors Grant 10,800,783 - Behenna , et al. October 13, 2 | 2020-10-13 |
| Substituted carbonucleoside derivatives useful as anticancer agents Grant 10,709,709 - Tatlock , et al. | 2020-07-14 |
| Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20200102334 - Wythes; Martin James ; et al. | 2020-04-02 |
| Cyclopentane-based modulators of STING (stimulator of interferon genes) Grant 10,538,542 - Wythes , et al. Ja | 2020-01-21 |
| Substituted nucleoside derivatives useful as anticancer agents Grant 10,428,104 - Tatlock , et al. October 1, 2 | 2019-10-01 |
| Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20190284216 - Wythes; Martin James ; et al. | 2019-09-19 |
| CDK2/4/6 Inhibitors App 20190135817 - Behenna; Douglas Carl ; et al. | 2019-05-09 |
| Substituted Carbonucleoside Derivatives Useful As Anticancer Agents App 20190111060 - Tatlock; John Howard ; et al. | 2019-04-18 |
| Aryl and heteroaryl fused lactams Grant 10,246,433 - Edwards , et al. | 2019-04-02 |
| Substituted carbonucleoside derivatives useful as anticancer agents Grant 10,220,037 - Tatlock , et al. | 2019-03-05 |
| CDK2/4/6 Inhibitors App 20180044344 - Behenna; Douglas Carl ; et al. | 2018-02-15 |
| Substituted Carbonucleoside Derivatives Useful As Anticancer Agents App 20170348313 - Tatlock; John Howard ; et al. | 2017-12-07 |
| Aryl And Heteroaryl Fused Lactams App 20170233368 - EDWARDS; Martin Paul ; et al. | 2017-08-17 |
| Benzamide And Heterobenzamide Compounds App 20170152239 - EDWARDS; Martin Paul ; et al. | 2017-06-01 |
| Substituted Nucleoside Derivatives Useful As Anticancer Agents App 20160244475 - Tatlock; John Howard ; et al. | 2016-08-25 |
| Benzamide And Heterobenzamide Compounds App 20150239842 - Edwards; Martin Paul ; et al. | 2015-08-27 |
| Aryl And Heteroaryl Fused Lactams App 20150175572 - EDWARDS; Martin Paul ; et al. | 2015-06-25 |
| Aryl and heteroaryl fused lactams Grant 9,040,515 - Edwards , et al. May 26, 2 | 2015-05-26 |
| Aryl And Heteroaryl Fused Lactams App 20140179667 - EDWARDS; Martin Paul ; et al. | 2014-06-26 |
| Heterocycles Useful As Inhibitors Of Carbonic Anhydrase App 20100256357 - Chong; Wesley Kwan Mung ; et al. | 2010-10-07 |
| Carbamate compositions and methods fo rmodulating the activity of the CHK1 enzyme App 20050148643 - Rui, Eugene Yuanjin ; et al. | 2005-07-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 